explore -WSS

explore

author：Wikipedia 2025-09-27 15:20:58 - browse：6255

Cambridge: Biogen — Ruby Wallau for STAT

Biogen, the iconic but embattled biotech firm, is shuttering Biogen Digital Health, its roughly 150-person group focused on using new types of data like those from mobile phones and smart watches, and ending a clinical trial being conducted with Apple early, STAT has learned.

Biogen confirmed the organizational change, but said it might lean even more on digital tech startups in the future.

“It’s certainly not an abandonment of digital, it’s more of a realignment of resources and priorities,” said Adam Keeney, Biogen’s executive vice president and head of corporate development. However, he later acknowledged, Biogen Digital Health, a separate entity, “would no longer continue in its current form.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Trump indictment: Who are the 'co

WSS

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Liquid biopsy for lung cancer is launched by Delfi

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

EQRx, failed developer of low

New safety details link Apellis eye drug to rare cases of blindness

What to expect at HLTH 2023, the health care industry conference

explore

explore

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Histogen: Failed biotech offers rare public look inside

New air purifier tech could be key to improving indoor air quality

5 important ways Henrietta Lacks changed medical science

Cancer drug shortages should be causing more outrage

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

After affirmative action ruling, medical educators look to 'holistic review'

Mitch McConnell episode has important public health takeaway

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Infectious disease expert Jeanne Marrazzo assumes Fauci role

focus

FDA authorizes Novavax’s updated Covid

Scientists inch closer to single

Senate panel eyes new effort on drug shortages

Phenylephrine and the overlooked value of the placebo effect

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Lawsuit alleges UnitedHealth Group unit illegally denied claims

hotspot

explore

leisure time

hotspot